Metabolite Probes Development Service
Metabolites are direct readouts of mitochondrial energy metabolism, redox balance, biosynthetic flux, nutrient utilization, drug response, and disease-associated metabolic reprogramming. MitoGlowing™ provides a comprehensive Metabolite Probes Development Service to support custom fluorescent probes, mass spectrometry labeling probes, isotope tracing probes, chemoselective enrichment probes, and assay workflows for metabolite imaging, mitochondrial metabolism research, drug metabolism studies, cancer metabolic profiling, microbiome interaction analysis, and high-throughput metabolomics applications.
Introduction to Metabolite Probes
Metabolites such as pyruvate, lactate, citrate, succinate, fumarate, acetyl-CoA, acylcarnitines, amino acids, fatty acid oxidation intermediates, nucleotides, and phosphorylated metabolites are closely linked to mitochondrial function and cellular energy status. Changes in metabolite abundance, localization, turnover, or pathway flux can reveal mitochondrial respiratory dysfunction, metabolic stress, drug-induced toxicity, tumor metabolic adaptation, immune cell reprogramming, and therapeutic response.
Unlike proteins or nucleic acids, metabolites are chemically diverse, structurally small, and often difficult to detect directly due to low abundance, high polarity, poor ionization efficiency, weak fluorescence, rapid turnover, or matrix interference. Therefore, metabolite probe development often requires analyte-specific recognition chemistry, derivatization strategy, enrichment design, stable isotope tracing, fluorescence activation, mass spectrometry compatibility, or pathway-responsive probe engineering.
Metabolite probes can be designed for live-cell fluorescence imaging, near-infrared imaging, confocal microscopy, high-content imaging, LC-MS/MS, MALDI-MS imaging, stable isotope probing, TMT-based multiplexed metabolomics, and high-throughput screening. For mitochondrial applications, metabolite probe workflows can be integrated with NADH/NAD⁺ ratio, ATP/ADP ratio, ROS, mitochondrial membrane potential, oxygen consumption, glycolysis, calcium, apoptosis, and cell viability assays to build a more complete energy metabolism profile.
Fig.1 The subcellular positioning of mitochondria in dictating subcellular energy levels.
Features of Metabolite Probes Development
- Metabolite-specific probe strategy design for small polar metabolites, organic acids, phosphorylated metabolites, fatty acid oxidation intermediates, amino acid derivatives, nucleotides, cofactors, and pathway-specific metabolite panels.
- Chemoselective labeling and enrichment with reactive groups for carbonyl, carboxyl, phosphate, amine, thiol, aldehyde, ketone, or other functional groups to improve detection, enrichment, and quantification of low-abundance metabolites.
- Mass spectrometry probe development including LC-MS/MS-compatible probes, isotope tags, TMT-compatible labeling, cleavable linkers, ionization-enhancing groups, chromatographic retention modifiers, and multiplexed quantification workflows.
- Fluorescent and imaging probe development using turn-on, ratiometric, near-infrared, organelle-targeted, or pathway-responsive fluorescent probes for live-cell metabolite imaging and metabolic activity visualization.
- Stable isotope and pathway tracing compatibility for metabolic flux analysis, drug metabolism tracing, microbiome-metabolite interaction studies, and low-abundance metabolite discovery.
- Application-specific validation in cancer metabolism, drug metabolism, mitochondrial dysfunction, microbiome interaction, hepatotoxicity, nephrotoxicity, metabolic disease, tumor imaging, and high-throughput screening models.
Our Services
MitoGlowing™ provides an integrated metabolite probe development workflow covering probe strategy design, molecular development, photophysical or MS-based characterization, biochemical validation, biological testing, and application-specific assay optimization.
Project Design & Metabolite Readout Strategy
- Define the target application, such as mitochondrial metabolism analysis, drug metabolite discovery, cancer metabolism profiling, microbiome interaction studies, metabolic flux tracing, or live-cell metabolite imaging.
- Select the preferred detection format, including fluorescent probe, near-infrared probe, LC-MS/MS labeling probe, isotope probe, TMT-compatible probe, chemoselective enrichment probe, or high-throughput assay workflow.
- Determine target metabolite class, such as organic acids, phosphorylated metabolites, carbonyl-containing metabolites, acyl metabolites, fatty acid oxidation intermediates, amino acid derivatives, cofactors, or nucleotide metabolites.
- Design validation strategies using metabolite standards, pathway inhibitors, isotope-labeled substrates, mitochondrial modulators, drug-treated samples, tissue extracts, and biological disease models.
Molecular Probe & Labeling Reagent Development
- Design metabolite-responsive probes based on fluorophores, cleavable chemoselective groups, isotope tags, ionization-enhancing groups, TMT-compatible handles, linker structures, and enrichment modules.
- Develop derivatization probes for carboxyl, carbonyl, phosphate, amine, thiol, aldehyde, ketone, or hydroxyl-containing metabolites.
- Introduce mitochondrial targeting groups, near-infrared fluorophores, solubility-enhancing groups, mass spectrometry reporter groups, or analyte-selective recognition motifs when required.
- Optimize reaction specificity, labeling efficiency, aqueous compatibility, background signal, matrix tolerance, and live-cell or sample-extraction compatibility.
- Support assay format development for live cells, cell lysates, plasma, serum, tissue extracts, microbiome samples, organoids, and high-throughput plates.
Photophysical, Chemical & MS Characterization
- Measure absorption spectra, emission spectra, excitation/emission maxima, fluorescence intensity, Stokes shift, quantum yield, and signal stability for imaging probes.
- Evaluate derivatization efficiency, reaction kinetics, enrichment recovery, cleavage efficiency, ionization enhancement, chromatographic retention, and MS/MS fragmentation behavior.
- Assess selectivity toward target metabolite classes and potential interference from structurally related metabolites, salts, proteins, lipids, cofactors, reducing agents, and biological matrix components.
- Test pH stability, buffer compatibility, solvent tolerance, serum tolerance, storage stability, and sample preparation robustness.
- Characterize multiplexing performance, isotope labeling accuracy, reporter ion generation, standard curve linearity, limit of detection, reproducibility, and batch-to-batch stability.
Biological Validation & Assay Development
- Validate probe performance in biological samples, including live cells, organoids, tissue extracts, plasma, serum, microbiome samples, or drug-treated models.
- Optimize sample extraction, probe labeling, enrichment, washing, cleavage, imaging, LC-MS/MS detection, or isotope tracing conditions.
- Test probe response in metabolic perturbation models, including mitochondrial inhibition, glycolytic shift, fatty acid oxidation modulation, nutrient stress, drug treatment, hypoxia/reoxygenation, or microbiome-drug interaction systems.
- Develop workflows for fluorescence microscopy, confocal imaging, high-content imaging, LC-MS/MS, MALDI-MS imaging, isotope tracing, TMT-based multiplexing, and high-throughput metabolomics screening.
- Establish quantitative analysis methods, including fluorescence intensity analysis, channel ratio analysis, peak area normalization, internal standard correction, isotope incorporation analysis, pathway enrichment, and differential metabolite discovery.
Supported Sample Types and Models
- Cancer cell lines, tumor spheroids, organoids, and tumor metabolism models
- Mitochondrial dysfunction, oxidative phosphorylation, glycolysis, and nutrient stress models
- Drug-treated, chemotherapy-treated, metabolic inhibitor-treated, or nanomaterial-treated cells
- Hepatocytes, liver injury models, fatty liver models, and drug metabolism models
- Kidney organoids, nephrotoxicity models, and renal tubular injury systems
- Microbiome samples, bacterial cultures, host-microbe co-culture systems, and gut metabolism models
- Cardiomyocyte, neuronal, immune, macrophage, and stem cell models
- Plasma, serum, whole blood, tissue extracts, cell lysates, and selected biological fluids
- 2D cultures, 3D organoids, tissue sections, and selected small animal models
- 96-well, 384-well, multiplexed MS, and high-throughput metabolomics formats
Application
High-Throughput Drug Metabolite Discovery
Chemoselective metabolite probes can improve the discovery of differential metabolites in drug-treated biological samples. A 2025 study reported MMCPT, a multiplexed metabolomics strategy that integrates chemoselective probes with TMT labeling to tag, enrich, enzymatically cleave, and label metabolites. The approach supports small polar metabolite analysis, multi-sample comparison, and selective metabolite identification in cells, plasma, and drug-treated models.
This application supports metabolite probe development for drug metabolism studies, lead compound optimization, differential metabolite discovery, cancer pharmacology, plasma biomarker screening, and multi-omics integration.
Mass Spectrometry Probe Development for Difficult Metabolites
Mass spectrometry labeling probes can improve the detection of metabolites that are highly polar, low-abundance, poorly retained, or weakly ionized. TMT- or derivatization-based probe strategies can enhance chromatographic retention, peak shape, and detection sensitivity for pathway intermediates such as mevalonate pathway metabolites, acylated metabolites, and other difficult-to-detect endogenous compounds.
This application supports probe development for hard-to-detect metabolic pathways, drug-induced metabolic remodeling, biomarker discovery, isomer analysis, and pathway-specific LC-MS/MS assay development.
Stable Isotope Probe Workflows for Drug-Microbiome Interaction Research
Stable isotope probing can help identify which organisms, proteins, or metabolites are actively involved in drug transformation within complex microbial communities. DNA-SIP, RNA-SIP, Protein-SIP, and Metabolite-SIP strategies can be used to trace labeled substrates, identify active microbial pathways, and capture transient or low-abundance metabolites.
This application supports metabolite probe and isotope tracing workflows for drug-microbiome interaction studies, microbial drug metabolism, probiotic or prebiotic activity evaluation, antibacterial efficacy studies, and low-abundance metabolite pathway analysis.
Fluorescent Metabolic Activity Probe Development
Fluorescent metabolic activity probes can visualize pathway activity in living cells and support functional metabolic phenotyping. Activatable fluorescent probes can be designed to respond to specific metabolites, enzymatic reactions, or pathway activity, including fatty acid oxidation, tumor energy metabolism, and mitochondrial metabolic remodeling.
This application supports fluorescent probe development for tumor metabolic visualization, mitochondrial metabolic activity imaging, fatty acid oxidation studies, live-cell metabolic phenotyping, drug effect evaluation, and non-invasive monitoring of metabolic pathway activity in preclinical models.
Our Advantages
- Integrated metabolite probe chemistry and assay validation: We combine molecular probe design, chemoselective labeling, fluorescence optimization, MS characterization, isotope tracing, and biological validation to generate metabolite probe workflows that are chemically robust and biologically meaningful.
- Mitochondria-focused metabolism expertise: Our platform supports metabolite probe development for mitochondrial respiration, fatty acid oxidation, TCA cycle metabolism, glycolytic adaptation, nutrient stress, and drug-induced metabolic dysfunction.
- Flexible detection strategy: We support fluorescent imaging, near-infrared imaging, LC-MS/MS labeling, TMT-compatible multiplexing, stable isotope probing, enrichment-based workflows, and high-throughput assay formats.
- Application-oriented probe optimization: Probe performance can be tailored for drug metabolism, cancer metabolism, microbiome interaction, metabolic disease research, hepatotoxicity, nephrotoxicity, organoid models, and preclinical biomarker discovery.
- Multi-parameter mitochondrial profiling: Metabolite probe analysis can be integrated with NADH/NAD⁺ ratio, ATP/ADP ratio, oxygen consumption, glycolysis, ROS, mitochondrial membrane potential, calcium, apoptosis, cell viability, and mitochondrial morphology assays to build a complete mitochondrial energy metabolism profile.
Contact Us
Develop sensitive, selective, and application-specific metabolite probes with Protheragen's Metabolite Probes Development Service. Contact us with your target metabolite class, biological model, preferred detection platform, sample type, throughput requirement, mitochondrial localization need, and research objective. Our team will recommend a tailored probe or assay development strategy for mitochondrial metabolism analysis, metabolite imaging, drug metabolism studies, cancer metabolic profiling, microbiome interaction research, and high-throughput metabolomics discovery.
Reference
1. Alshaabi, H., et al. (2020). Dynamic regulation of subcellular mitochondrial position for localized metabolite levels. Journal of biochemistry, 167(2), 109–117.
